CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report)’s share price fell 0.4% during mid-day trading on Monday. The stock traded as low as C$4.39 and last traded at C$4.45. Approximately 1,300 shares were traded during trading, a decline of 57% from the average session volume of 3,035 shares. The stock had previously closed at C$4.47.
CSPC Pharmaceutical Group Price Performance
The company has a 50 day simple moving average of C$4.67 and a 200 day simple moving average of C$4.29.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.
Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs.
Recommended Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
